Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality
The Indian Journal of Medical Research · 2024
DOI: 10.25259/ijmr_2516_22 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2024. Verfasst von Alfian Nur Rosyid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology and Respiratory Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Mucin-1, SARS-CoV-2, Severity of Illness Index. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background & objectives Krebs von den Lungen-6 (KL-6) is primarily expressed by the damaged type II pneumocytes. In this context, the relationship of KL-6 with blood gas analysis (BGA) parameters and Brixia score is still limitedly discussed. This study aims to analyze the correlation of KL-6, BGA and Brixia scores to the severity and mortality of COVID-19.
Methods
A cross-sectional study was conducted in adult COVID-19 positive individuals at Universitas Airlangga Hospital, Surabaya, East Java, Indonesia, from March to August 2021. KL-6, BGA, and Brixia scores were compared according to severity (severe vs. non-severe) and mortality (non-survivor vs . survivor). The receiver operating characteristic (ROC) analysis was also performed to define the optimal cut-off, sensitivity, as well as the specificity of KL-6, BGA and Brixia scores to determine the COVID-19 severity and mortality.
Results
Total 35 severe and 20 non-severe COVID-19 positive individuals were enrolled in this study. Of those, there were 22 non-survivors. No significant difference in serum KL-6 levels was observed in the severity and mortality groups. KL-6 and HCO 3 – had positive correlation in the severe group ( r =0.37). KL-6 and Brixia scores showed a significant negative correlation among COVID-19 positive individuals ( r =–0.283; P =0.036). KL-6 and Brixia scores together served as the best severity markers in the current study [AUC 0.809 (0.697–0.920); Sn/Sp=0.686/0.900)], followed by KL-6 and P/F ratio [AUC 0.800 (0.637–0.963); Sn/Sp=0.971/0.750]. Interpretation & conclusions The findings of this study suggest that KL-6 has the potential to be a useful adjunct laboratory parameter to the BGA and Brixia score representing COVID-19 severity and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology and Respiratory Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.
- Department of Clinical Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia.
- Department of Radiology, Universitas Airlangga Hospital, Surabaya, Indonesia.
Zitieren
APA
Rosyid, A. N., Witarto, A. P., Witarto, B. S., Putra, A. J. E., Pramudito, S. L., Soebakti, E., Sensusiati, A. D., Nugraha, J., & Amin, M. (2024). Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_2516_22
Vancouver
Rosyid AN, Witarto AP, Witarto BS, Putra AJE, Pramudito SL, Soebakti E, et al. Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality. The Indian Journal of Medical Research. 2024. doi:10.25259/ijmr_2516_22
BibTeX
@article{Rosyid2024,
author = {Rosyid, Alfian Nur and Witarto, Andro Pramana and Witarto, Bendix Samarta and Putra, Achmad Januar Er and Pramudito, Shidi Laras and Soebakti, Erika and Sensusiati, Anggraini Dwi and Nugraha, Jusak and Amin, Muhammad},
title = {Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality},
journal = {The Indian Journal of Medical Research},
year = {2024},
doi = {10.25259/ijmr_2516_22}
}
EUVIMED